Inquiries Into the Mechanisms by Which GLP-1 Receptor Agonists Reduce Cardiovascular Risk in Diabetes. Inzucchi SE, Arai AE. J Am Coll Cardiol 2024;84:558-560.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Inzucchi SE, Arai AE. Inquiries Into the Mechanisms by Which GLP-1 Receptor Agonists Reduce Cardiovascular Risk in Diabetes. J Am Coll Cardiol 2024;84:558-560.
PMID: 39084830